FALLICA, ANTONINO NICOLO'
 Distribuzione geografica
Continente #
NA - Nord America 451
EU - Europa 294
AS - Asia 127
AF - Africa 51
SA - Sud America 32
OC - Oceania 2
Totale 957
Nazione #
US - Stati Uniti d'America 446
IT - Italia 167
SG - Singapore 89
IE - Irlanda 43
CI - Costa d'Avorio 41
BR - Brasile 30
DE - Germania 30
CN - Cina 29
ES - Italia 19
RU - Federazione Russa 8
SN - Senegal 8
FI - Finlandia 7
GB - Regno Unito 5
KR - Corea 5
CA - Canada 4
UA - Ucraina 4
CH - Svizzera 3
AU - Australia 2
FR - Francia 2
KE - Kenya 2
SE - Svezia 2
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
GY - Guiana 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MX - Messico 1
NL - Olanda 1
PK - Pakistan 1
Totale 957
Città #
Chandler 112
Santa Clara 97
Singapore 66
Dublin 43
Catania 42
Abidjan 41
Chicago 34
Ashburn 24
Boardman 22
Barcelona 15
Bremen 11
Cambridge 11
Civitanova Marche 11
Lawrence 11
Andover 10
Dakar 8
Hefei 7
São Paulo 7
Los Angeles 6
Munich 6
Redmond 6
Turku 6
Rome 5
Seoul 5
Wilmington 5
Moscow 4
Salerno 4
Arezzo 3
Dallas 3
Des Moines 3
Gela 3
Nanjing 3
Padova 3
Palermo 3
Pozzallo 3
Santa Maria di Licodia 3
Brooklyn 2
Cagliari 2
Ferrara di Monte Baldo 2
Foggia 2
Ludwigshafen 2
Madrid 2
Nairobi 2
Nanchang 2
Naples 2
Seattle 2
Toronto 2
Amman 1
Ananindeua 1
Atripalda 1
Augusta 1
Baghdad 1
Bariri 1
Beijing 1
Belford Roxo 1
Brno 1
Calgary 1
Canberra 1
Canoas 1
Caruaru 1
Charlotte 1
Columbus 1
Corigliano Calabro 1
Curitiba 1
Dongyang 1
Edinburgh 1
El Paso 1
Esslingen am Neckar 1
Fairfield 1
Ferrara 1
Garbagnate Milanese 1
Georgetown 1
Goiânia 1
Guarujá 1
Hebei 1
Helena 1
Hwang Chow 1
Itaboraí 1
Jackson 1
Jinzhong 1
Juneau 1
Lahore 1
Lappeenranta 1
Latina 1
Leawood 1
London 1
Londrina 1
Luxembourg 1
Manchester 1
Marseille 1
Melbourne 1
Messina 1
Milan 1
Misterbianco 1
New York 1
Novara 1
Nuremberg 1
Ottawa 1
Petrópolis 1
Phoenix 1
Totale 721
Nome #
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 122
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents 89
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 75
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective 75
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors 74
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 69
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation 65
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 65
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 60
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects 57
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 52
The potential role of sildenafil in cancer management through epr augmentation 42
Curcumin I-SMA nanomicelles as promising therapeutic tool to tackle bacterial infections 41
Targeting del sistema enzimatico dell'eme ossigenasi come nuovo approccio nella terapia antitumorale 39
Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer 36
The Promise of Nanotechnology in Personalized Medicine 34
Totale 995
Categoria #
all - tutte 3.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 3 9 8 0 2 2 0 1 4 3
2021/2022130 11 8 24 3 16 2 23 10 7 5 0 21
2022/2023264 26 18 7 45 23 45 1 36 45 2 12 4
2023/2024126 4 13 4 3 12 55 1 2 3 6 13 10
2024/2025408 5 53 18 36 90 56 15 4 22 38 40 31
2025/20264 4 0 0 0 0 0 0 0 0 0 0 0
Totale 995